FROM METABOLISM TO CLOT FORMATION : Acetyl-CoA as a central mediator in platelet reactivity and thrombosis

Summarise with VIRAT
Authors: Laurence Pirotton
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Current antiplatelet therapies reduce thrombotic complications in cardiovascular disease but increase bleeding risk, underscoring the need for safer strategies. This thesis investigates platelet metabolism as a therapeutic target, focusing on acetyl-CoA carboxylase (ACC) and ATP-citrate lyase (ACLY). Using genetic and pharmacological approaches, we show that ACLY inhibition by bempedoic acid produces methodology-dependent pro- or anti-thrombotic effects driven by altered tubulin acetylation. In contrast, platelet-specific deletion of ACC protects against thrombosis while preserving normal haemostasis, through extensive phospholipidome remodelling, including reduced arachidonic acid–containing plasmalogens required for thromboxane A₂ synthesis. These protective effects persist under hypercholesterolemic conditions. Overall, this work identifies acetyl-CoA metabolism as a key regulator of platelet function and a promising target to prevent thrombosis.

Fields of Study & Subjects

Platelet Disorders and Treatments Blood Coagulation and Thrombosis Mechanisms Antiplatelet Therapy and Cardiovascular Diseases

Publication details

Journal / source
Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B))
Publication date
1 January 2026
Language
EN
Document type
Thesis